Importantly, siRNA specifically targeting GSTA1 reduced the inhibitory effect of bicyclol on TG level (Figure 5D), indicating the critical role of GSTA1 in mediating the anti-steatosis effect of bicyclol. The gene discussed is GSTA1; the disease is steatosis.